dc.creatorGonzález, Magdalena
dc.creatorMartínez, Rafael
dc.creatorAmador, Cristián
dc.creatorMichea Acevedo, Luis
dc.date.accessioned2019-03-11T12:58:15Z
dc.date.available2019-03-11T12:58:15Z
dc.date.created2019-03-11T12:58:15Z
dc.date.issued2009
dc.identifierCurrent Vascular Pharmacology, Volumen 7, Issue 4, 2018, Pages 506-512
dc.identifier15701611
dc.identifier10.2174/157016109789043946
dc.identifierhttps://repositorio.uchile.cl/handle/2250/164849
dc.description.abstractVascular calcification is caused by the deposition of basic calcium phosphate crystals in blood vessels, myocardium, and/or cardiac valves. Calcification decreases artery wall compliance, and arterial calcification is associated to mortality in hyperphosphatemic renal failure and diabetes mellitus. The calcification of the tunica media characterizes the arteriosclerosis observed with age, diabetes and end stage-renal disease, and it can develop independently from intima calcification. As part of the vascular calcification mechanism, vascular smooth muscle cells (VSMC) experience a transition from a contractile to an osteochondrogenic phenotype and a sequence of molecular events that are typical of endochondral ossification. The current evidence indicates a key role of increased phosphate uptake by VSMC for calcification, which supplies the substrate for hydroxyapatite formation and could trigger or potentiate VSMC transdiferentiation. The present review analyzes the sodium-phosphate co
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceCurrent Vascular Pharmacology
dc.subjectAtherosclerosis
dc.subjectBone morphogenetic proteins
dc.subjectChronic kidney disease
dc.subjectDiabetes
dc.subjectHyperphospatemia
dc.subjectPhosphate transport
dc.subjectVascular calcification
dc.titleRegulation of the sodium-phosphate cotransporter Pit-1 and its role in vascular calcification
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución